CONTINUED EFFICACY AND SAFETY THROUGH 4 YEARS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN HBEAG-NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B (STUDY 102): PRELIMINARY ANALYSIS

被引：0

作者：

Marcellin, Patrick ^{[2
]}

Buti, Maria ^{[3
]}

Krastev, Zahary ^{[4
]}

Gurel, Selim ^{[5
]}

Di Bisceglie, Adrian M. ^{[6
]}

Odin, Joseph A. ^{[7
]}

Dusheiko, Geoffrey M. ^{[8
]}

Heathcote, E. Jenny ^{[9
]}

Borroto-Esoda, Katyna ^{[1
]}

Coombs, Derek H. ^{[1
]}

Mondou, Elsa ^{[1
]}

Anderson, Jane ^{[1
]}

机构：

[1] Gilead Sci, Durham, NC USA

[2] Univ Paris, Hop Beaujon, Clichy, France

[3] Univ Vall Hebron & Ciberehd, Serv Med Interna Hepatol, Gen Hosp, Barcelona, Spain

[4] Univ Hosp St Ivan Rilsky, Sofia, Bulgaria

[5] Uludag Univ, Bursa, Turkey

[6] St Louis Univ, Sch Med, St Louis, MO USA

[7] Mt Sinai Sch Med, New York, NY USA

[8] Royal Free Hosp, London NW3 2QG, England

[9] Univ Toronto, Toronto, ON, Canada

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

476

引用

页码：555A / 556A

页数：2